Skip to content

Effect of interferential current combined with exercise in patients with fibromyalgia: randomized clinical trial

Effect of interferential current combined with exercise on fibromyalgia: randomized clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-6dk3y3
Enrollment
Unknown
Registered
2016-12-27
Start date
2016-12-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

Subjects, included in the study, will be randomly divided into two groups: Active and Placebo. In the Active group: Forty patients will receive 24 treatment sessions, each session consists of an exer
Other
E02.331
E02.779.483

Sponsors

Universidade Federal de Sergipe
Lead Sponsor
Universidade Federal de Sergipe
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with fibromyalgia, diagnosed according to the criteria of the American College of Rheumatology, female, aged 18 to 60 years, without physical therapy concomitant.

Exclusion criteria

Exclusion criteria: Subjects will be excluded if they have concomitant rheumatologic disease, severe psychiatric disorders or any contraindication to prevent the use of interferential current, such as allergies to the electrodes, cardiac pacemaker, pregnancy, epilepsy, skin conditions or deficient skin sensation in the areas of electrode placement.

Design outcomes

Primary

MeasureTime frame
Reduction of pain of the patients submitted treatment with active interferential current and exercise. For the assessment of pain reduction, the numerical scale of 11 points, pressure pain threshold, Mcgill pain questionnaire, temporal summation test and modulation conditioned of pain test will be used. And for verification the expected outcome, a variation of at least 5% in each test, questionnaire and scale used pre, middle and post intervention will be considered.

Secondary

MeasureTime frame
Improvement of the quality of life, sleep quality, muscle strength and cutaneous sensitive threshold. Reduction of depression, anxiety, physical disability, pain-related negative expectations, fear of movement, red areas marked in thermographic image and number of cytokines. To assess these variables, will be used: Fibromyalgia Impact Questionnaire, Short Form 36 Health Survey, Pittsburgh Sleep Quality Index, dynamometer, Von Frey filaments, Beck Depression Inventory, State-Trait Anxiety Inventory, Roland Morris Disability Questionnaire, sit to stand test, six-minute walk test, Pain Catastrophizing Scale, Tampa Kinesiophobia Scale, infrared thermographic camera and blood collection. For verification of the expected outcomes, a variation of at least 5% in each scale and questionnaire used pre, middle and post intervention will be considered.

Countries

Brazil

Contacts

Public ContactFernanda Araújo

Universidade Federal de Sergipe

nanda.maraujo@hotmail.com+55(79)32312841

Outcome results

None listed

Source: REBEC (via WHO ICTRP)